Institutional Ownership
Crescent Biopharma Inc.
CUSIP 38000Q201COMCBIOQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
10.3%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Oct 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 14, 2025 | 1globe Capital LLC | 13G/A | 10.3% | 1.43M | SEC |
| 2 | Aug 20, 2025 | 1globe Capital LLC | 13G | 6.5% | 896.7K | SEC |
| 3 | Jul 8, 2025 | Fmr LLC | 13G | 10.2% | 1.41M | SEC |
| 4 | Jun 23, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G | 9.9% | 1.39M | SEC |
| 5 | Jun 20, 2025 | Adage Capital Management, L.P. | 13D/A | 0.4% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boxer Capital Management, LLC | 453.7K | $8.33M |
| 2 | Remedium Capital Partners, LLC | 361.3K | $6.64M |
| 3 | Quadrature Capital Ltd | 20.9K | $384.2K |